arrow
S

Sameer Bakhshi

All India Institute of Medical Sciences
H指数:43
被引数:8,739

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacogenetic Predictors of Chemotherapy Treatment-Related Toxicities in Paediatric and Adolescent Acute Lymphoblastic Leukemia: A Systematic Review, Meta-Analysis and Literature-Based Candidate Prioritization

化疗治疗相关毒性的儿科和青少年急性淋巴细胞白血病药代遗传学预测因子:系统综述、Meta分析和文献来源候选基因优先排序

2026-08-020
OA
Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study

MPGx-INDALL:急性淋巴细胞白血病治疗中分子和药物遗传学标记物与毒性和临床反应关系的评估——前瞻性观察性队列研究方案

2026-01-010
PRE
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): international, multi-center collaboration and global registry program

blastic plasmacytoid dendritic cell neoplasm (BPDCN):国际、多中心合作和全球登记项目

2025-12-210
OAAI
Early stoppage of empirical antibiotic therapy in paediatric acute leukaemia with high-risk febrile neutropenia: a randomized, open-label, phase 3, non-inferiority trial

儿童急性白血病伴高风险发热性中性粒细胞减少症患者经验性抗生素治疗的早期终止:一项随机、开放标签、III期非劣效性试验

2025-10-300
OAAI
Application of Targeted RNA-Sequencing in High-Risk B-Cell Acute Lymphoblastic Leukemia (B-ALL): Identifying Fusions, IKZF1 Deletions, and CRLF2 Expression in an Indian Cohort

靶向RNA测序在高风险B细胞急性淋巴细胞白血病(B-ALL)中的应用:识别融合基因、IKZF1缺失以及CRLF2表达在一个印度队列中

2025-09-010
PRE
Gene expression signature of IKZF1 deleted B-cell acute lymphoblastic leukaemia reveals a unique regulation of MUC4

IKZF1缺失的B细胞急性淋巴细胞白血病基因表达特征揭示了MUC4的独特调控机制

2025-08-280
PRE
Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India

儿童急性淋巴细胞白血病的风险分层治疗:一项来自印度的多中心观察性研究

2025-06-010
PRE
Integrative Genetic and Transcriptomic Subtyping Improves Prognosis Prediction in B-Lineage Acute Lymphoblastic Leukemia

整合遗传和转录组学分型可改善B系急性淋巴细胞白血病的预后预测

2025-05-290
PRE
Delphi Survey on Measurable Residual Disease in Multiple Myeloma: Prevailing Practices and the Way Forward in India

关于多发性骨髓瘤可测量残留病灶的德尔菲调查:印度的现行实践及未来方向

2025-05-210
PRE